The fat mass and obesity-associated gene (FTO), a crucial gene that affects human obesity and metabolism, has been widely studied in mammals but remains poorly characterized in birds. We aimed to identify variant FTO transcripts in domestic avian species, and to characterize the expression and biological functions of FTO in chickens. METHODS: Variant FTO transcripts and their expression in birds were investigated using RACE and real-time quantitative reverse transcriptase-PCR technology. The effects of FTO on glucose metabolism, growth and body composition were determined by fasting and various diet treatments, as well as association analysis in a F 2 resource population. The function of cFTO1 was further studied by overexpression in chick embryo fibroblast (CEF) cells. RESULTS: Variant FTO transcripts were identified in chicken (cFTO1 to cFTO4), duck (dFTO1, dFTO2 and dFTO4) and goose (gFTO1, gFTO2 and gFTO5). In the chicken, the complete transcript (cFTO1) was predominantly expressed in the leg muscle, pituitary, hypothalamus and cerebellum. Fasting increased both cFTO1 and PGC1a gene expression in the cerebrum, liver, breast muscle and subcutaneous fat, but decreased expression in the pituitary and anterior hypothalamus. In all tested tissues in chickens, a high-glucose diet markedly increased cFTO1 and PGC1a expression. Feeding a high-fat diet increased both cFTO1 and PGC1a expression, except in the pituitary. Overexpression of cFTO1 in CEF cells significantly increased the expression of PGC1a (2.5-fold), STAT3 (2.2-fold) and HL (1.5-fold), a cluster of genes related to energy metabolism. A total of 65 single nucleotide polymorphisms (SNPs) were identified in chicken FTO, and 18 tested SNPs were significantly associated with traits of body weight, body composition and fatness. CONCLUSIONS: These data collectively indicate that FTO is related to glucose metabolism, body weight, fatness and body composition in birds, thus expanding knowledge of FTO function to non-mammalian species.
INTRODUCTION
The epidemic of human obesity, with its associated high risk for many metabolic diseases, has attracted much attention in recent years. The fat mass and obesity-associated gene (FTO) was recently identified as an obesity candidate gene by three largescale and independent genome-wide association studies, which strongly associated several single nucleotide polymorphisms (SNPs) of FTO with obesity-related traits, including body mass index, hip circumference and body weight. 1 --3 Significant associations between FTO and obesity were independently replicated in many other studies of different populations, including Korean, 4 Japanese, 5 Malay, 6 Chinese, 6, 7 Belgian, 8 British, 9,10 Dutch, 11, 12 German, 13 Finnish, 14 French, 15 Swedish, 16, 17 Caucasian, 18 African 19 and American. 18,20 --22 In mice, FTO deficiency caused postnatal growth retardation and a significant reduction in adipose tissue and lean body mass, 23 and FTO deletion resulted in lesser postnatal growth and lower serum IGF-1 levels. 24 Another mouse model with a missense mutation in FTO maintained linear growth but developed a lean phenotype. 25 Overexpression of FTO leads to a dose-dependent increase in body weight and fat mass, irrespective of whether the mice were fed a standard or a high-fat diet. 26 Associations of FTO SNPs with body weight and fatness traits were also confirmed in pig. 27, 28 FTO is widely expressed in multiple tissues in mammals and highly expressed in brain and hypothalamus, which are crucial for body weight control. 24, 29 Fasting reduced the levels of FTO mRNA in the arcuate nucleus of the rat hypothalamus, whereas feeding increased FTO expression. 30 In type 2 diabetes, FTO was increased in the muscle, which altered insulin signaling, enhanced lipogenesis and reactive oxygen species production, and induced mitochondrial dysfunction in myotubes. 31 Intraperitoneal glucose injection reduced hepatic FTO mRNA levels in mice, but there were positive correlations between hepatic FTO mRNA expression and gluconeogenic gene expression. 32 This positive correlation was supported by another study, which also demonstrated that FTO mRNA was negatively associated with fat mass in skeletal muscle. 33 Little information is available regarding FTO in avian species. We hypothesize that FTO is also involved in body weight gain and fat mass accumulation in birds, and therefore we performed the current study to identify and characterize FTO by using the chicken as a model species for Aves.
MATERIALS AND METHODS Animals
Three, 7-week-old, female broiler chickens from each of Qingyuan Partridge (QYP) and Recessive White Rock (WRR) lines were used to clone and analyze the expression of FTO. QYP is a Chinese native chicken breed that has a much slower growth rate and lower fat deposition than WRR. An F 2 resource population (XH&WRR) with deep phenotyping records, previously described by Lei et al., 34 was used for association analysis of FTO variation with chicken growth, body composition and fatness traits. One Sanshui White duck (SW) and one Shitou goose (ST) obtained from a commercial market (Guangzhou Fangcun Huadiwan Flower Bird Fish & Insect market, Guangzhou, China) were used to clone the duck and goose FTO. All experiments with live birds were conducted following animal care protocols approved by South China Agricultural University, Guangdong Province, China.
Fasting and various diet treatments
A total of 10, 2-month-old, female Guangdong Yuehuang chickens (GY) weighing 630 --640 g, were divided into two groups (fasting and control, n ¼ 5 each). All birds were raised in individual cages, kept in identical light/ dark cycles and were provided with free access to water by an automatic watering system. Fasting was initiated at 5:00 pm and lasted for 72 h. In addition, three groups of GY females (n ¼ 5 each) were fed a highglucose diet (50% glucose), a high-fat diet (50% animal fat) or a basal diet, respectively. Birds had continual access to the treatment diets for one week, and were then euthanized to collect various tissues and phenotypes.
DNA and RNA isolation
Genomic DNA was extracted from EDTA-anticoagulated blood by using a standard phenol/chloroform method. Three tissues (the hypothalamus, breast muscle and leg muscle) of QYP and ST were used for complementary DNA (cDNA) cloning and splicing analysis of chicken FTO. From each of 3 QYP and 3 WRR female chickens, 10 tissues were collected and quick frozen in liquid nitrogen to isolate total RNA for real-time reverse transcriptase-PCR (RT-PCR) analysis. These tissues were cerebrum, cerebellum, hypothalamus, pituitary, heart, liver, breast muscle, leg muscle, subcutaneous fat and abdominal fat. Total RNA was extracted from each tissue using a single-step RNA isolation method (Invitrogen, Foster City, CA, USA) following the manufacturer's instructions. All obtained RNA samples were checked for quality and quantity by 1.5% agarose gel electrophoresis and evaluated for OD 260/280 ratio.
Primers
On the basis of conserved region alignment of FTO between human (NM_001080432) and mouse (NM_011936), primer P-M was designed to clone partial cDNA of chicken FTO. Thereafter, other three primers (P-Race1, P-Race2 and P-Race2N) were used to clone the full-length cDNA of FTO from chicken, duck and goose. FTO-Q1 was used for real-time-PCR analysis of chicken cFTO1, and b-actin was used as an internal control by using the primer p-actin. P1 --P11 were used to identify and genotype SNPs of chicken FTO. The remaining eight primers were used to test the expression of the corresponding genes by real time-PCR analysis. Primers were designed by Premier Primer 5.0 software (Premier Biosoft International, Palo Alto, CA, USA) and synthesized by Biosune Co. Ltd (Shanghai, China) with commercial service (Primers are summarized in Supplementary  Table 1) .
RT-PCR, 5
0 RACE and 3 0 RACE Random primers, oligo dT primers and M-MLV reverse transcriptase (Promega, Madison, WI, USA), were used to synthesize cDNA templates with 2 mg of total RNA following the manufacturer's instructions. The 50 ml RT-PCR mixtures contained 3 ml of 50 ng ml À1 cDNA, 5 ml of 10 Â buffer, 5 ml of 2.5 mmol l À1 dNTPs and 2 U Taq polymerase (Takara Bio Inc., Otsu, Japan). RT-PCR was run using the following condition: first, RNA annealing at 65 1C for 5 min, then placing on ice for over 1 min; preparing the reaction mixture and incubating at 42 1C for 60 min; subsequently, the reverse transcriptase was inactivated at 72 1C for 10 min. After first-strand synthesis, the cDNA was diluted to a final volume of 150 ml and was normalized using b-actin as the reference. RACE PCR was performed with the SmartRace kit (Takara, Shiga, Japan) following the manufacturer's instructions. Products of RACE and RT-PCR were cloned into pMD-18T (Takara) and sequenced by Invitrogen Co. Ltd (Guangzhou, China).
FTO database and phylogenetic analysis
The full-length FTO cDNA sequences of 22 species were used for phylogenetic analysis, including those of chicken (Gallus gallus: NP_001172076), duck (Anas platyrhynchos: ADH51649.1) and goose (Anser anser: ADH51652.1) that were newly obtained in the current study, as well as sequences of the other species from Genebank (http://www.ncbi.nlm. nih.gov/) (Supplementary Table 2 
Construction of cFTO1 overexpression vector, cell culture and transfection
The coding sequences of cFTO1 were amplified by primer P-CDs, and then cloned into pcDNA3.1( þ ) (Invitrogen) after being digested by Nhe I and EcoR V. The recombinant vector is designated as pcDNA3.1( þ )-cFTO1. Normal chick embryo fibroblast (CEF) cell lines were obtained from 10-dayold QYP chicks. CEF cells were cultured in Dulbecco's modified Eagle's medium (Gibco, Grand Island, NY, USA), with 10% fetal bovine serum (Hyclone Laboratories, Logan, UT, USA), 100 IU ml À1 penicillin and 100 lg ml À1 streptomycin in humidified air at 37 1C with 5% CO 2 . Lipofectamine 2000 (Invitrogen) was used to transfect pcDNA3.1( þ )-cFTO1 into CEF cells with 2 mg per well in 12-well plates, and cells were collected after 48 h to assay the mRNA change of related genes. The pcDNA3.1( þ ) vector without insert was used as the control.
SNP identification by PCR and sequencing
With genomic DNA from 10 random birds from the XH&WRR line cross as templates, 11 primers (P1 --P11) were used to amplify different regions (exons, introns, and UTRs) of chicken FTO (Supplementary Table 1) . PCR was performed in 15 ml of a mixture containing 50 ng of chicken genomic DNA, 1 Â PCR buffer, 5 pmol of primers (P1 --P5), 100 mM of each dNTP, 1.5 mM MgCl 2 and 1 U Taq DNA polymerase (Takara, Japan). PCR was conducted using the following protocol: 3 min at 94 1C, followed by 32 cycles of 30 s at 94 1C, 30 s at annealing temperature (58 --62 1C), 45 min at 72 1C and a final extension of 5 min at 72 1C. PCR products were sent to Invitrogen Co. Ltd for sequencing. The 110 obtained sequences were analyzed by using SeqMan II software (http://www.dnastar.com/t-productslasergene.aspx) to identify SNPs and other variations in the XH&WRR resource population.
Genotyping by sequencing and PCR-restriction fragment length polymorphism (PCR-RFLP)
As most SNPs in FTO that have been previously associated with obesity or body weight reside in non-coding regions, 18 SNPs designated as M1 --M18 (all located in non-coding regions except for M16) were chosen to genotype all samples (n ¼ 76 --479, depending upon marker and trait) of the XH&WRR F 2 resource population for association analysis. Genotyping was performed by either directly sequencing (M1 --M11) or PCR-RFLP technology (M12 --M18) (Supplementary Table 2 ). All PCR mixtures and protocols were the same as that of the SNP identification as described above. For M1 --M11, sequencing profiles were used to determine genotypes. For M12 --M18, PCR products were digested overnight in the mixture containing 8 ml PCR products, 1 Â digestion buffer and 4 U of specific restriction enzymes, then analyzed for RFLP profiles after electrophoresis through 2% agarose gel (Supplementary Table 2 ). Ultimately, genotypes for all samples of the XH&WRR F 2 resource population were determined according to RFLP profiles with 2% agarose gel electrophoresis.
Statistical analysis
All data are presented as means ± s.e.m. The two-tailed Student's t-test was used when comparing mRNA levels in varied tissues or breeds and treatment in the same group of subjects. The threshold for significance was set at Po0.05 and for high significance at Po0.01. Linkage disequilibrium estimation among 18 SNPs was performed using the Haploview 3.2 program based on genotype data. 35 SNPs that do not follow Hardy --Weinberg equilibrium are excluded from linkage disequilibrium analysis.
Association analysis of SNPs and biological traits were performed using the General Linear Models Procedures of SAS 8.1 (SAS Institute Inc., Cary, NC, USA) using the following model:
where Y ¼ the dependent variable; m ¼ the overall population mean; S i ¼ the fixed effect of the sex; B j ¼ the fixed effect of hatch; G k ¼ the fixed effect of genotype; F x ¼ random effect of dam; e ijkx ¼ the residual random error. With the above model, the hatch weight and the harvest weight were used as covariants in analyzing overall growth and fatness traits. Multiple comparisons were analyzed with the least square means to display significant differences among genotypes with the Duncan's Multiple Range test.
RESULTS
The chicken FTO cDNA and variant transcripts Four FTO transcripts were identified in the chicken; cFTO1 (NCBI accession number: HM050377), cFTO2 (HM050378), cFTO3 (HM050379) and cFTO4 (HQ874647) (Figure 1 ). UCSC genome BLAT (http://genome.ucsc.edu/cgi-bin/hgBlat) showed that the chicken FTO was over 268 Kb comprising nine exons and eight introns. The cFTO1 has a 1524 bp open reading frame encoding 507 amino acids (AA). For cFTO2, a 583 bp deletion in exon 3 led to a frame-shift variation and a premature stop codon, which translates a truncated FTO peptide (73 AA). The cFTO3 was comprised of exon 1, 2 and parts of exons 3 and 9, and produces a short FTO precursor of 228 AA. The cFTO4 consisted of the whole exons 1, 2 and 3, encoding a 283 AA peptide. Exon 3 and 4 are 'hot spots' for alternative splicing (Figure 2a ).
The duck and goose FTO cDNA and variant transcripts In the duck, three FTO transcripts were found: dFTO1 (NCBI accession number: HM050380), dFTO2 (HM050382) and dFTO4 (HM050381). In the goose, three FTO transcripts were found; gFTO1 (HM050383), gFTO2 (HM050385) and gFTO5 (HM050384). Goose FTO5 was generated by a 52 bp deletion at 5 0 UTR and a 186 bp deletion at carboxy-terminal domain, and it was unique to the goose (Figure 2b ). Comparing among the three avian species, FTO1 and FTO2 were present in all three species, and FTO5 was found only in the goose (Figure 2 ).
Sequence alignment and phylogeny analysis BLAST analysis of FTO among 22 species showed that four conserved domains (92 --118th AA, 233 --285th, 365 --397th and 454 --469th) and two motifs (VAVY and SSTHRV) were present in 22 precursors. FTO also existed in Saccoglossus kowalevskii, which is a member of the phylum hemichordate and is recognized as one of the oldest animals. The generated phylogenetic tree showed that the 22 species clustered into six distinct groups with high UPGMA bootstrap support this (up to 90%) (Supplementary Figure 1) . S kowalevskii, Danio rerio and Xenopus laevis were clustered into three individual groups, representing invertebrates, fish and amphibians, respectively. Three domestic birds and five algaes represented groups of birds and plants. Mammals, including 10 species, were clustered into the largest group with 99% bootstrap value, compared with the avian branch (Supplementary Figure 1) .
Tissue specific expression of cFTO1 between QYP and WRR The complete transcript, cFTO1, was predominantly expressed in the leg muscle, pituitary, hypothalamus and cerebellum in both QYP and WRR (Figure 3) . In cerebellum, however, it was significantly higher in QYP than in WRR (fold-change ¼ 3.4; P ¼ 0.01).
Fasting and diet treatment effects on cFTO1 and PGC1a mRNA level Fasting increased cFTO1 expression in the cerebrum, liver, breast muscle, cerebellum and subcutaneous fat, but decreased expression in the posterior hypothalamus, abdominal fat, pituitary and anterior hypothalamus (Figure 4a ). Fasting increased PGC1a expression, compared with non-fasted chickens, in the liver, subcutaneous fat, cerebellum, abdominal fat, breast muscle and posterior hypothalamus, but decreased PGC1a expression in the anterior hypothalamus, cerebrum and pituitary and anterior hypothalamus (Figure 4b) . Consuming a high-glucose diet markedly increased both cFTO1 and PGC1a expression in all tested tissues, and a high-fat diet seemed to increase PGC1a expression more than that of cFTO1 (Figures 4c and d) . were also significantly increased ( Figure 5 ). cFTO1 overexpression further upregulated the expression of growth hormone secretagogue receptor (GHSR), AMP-activated protein kinase b (AMPKb) and insulin-like growth factor 1 receptor (IGF1R) gene (P40.05), but had little effect on the leptin receptor (Leptin-R) and proxisome proliferator-activated receptor a (PPARa) genes (P40.05; Figure 5 ).
SNPs
By sequencing and BLAST analysis of 8005 bp of chicken FTO, we identified 67 variations (65 SNPs and 2 indels) in total (Supplementary Table 3 ). The SNPs were distributed in the flanking region (7 SNPs in 425 bp), UTR (14 SNPs in 980 bp), exons (6 SNPs in 1524 bp) and introns (38 SNPs in 5076 bp). Five SNPs changed encoded AA; G4677213A (Ala467Val), T4886652A (Leu158Ile), G4886441A (Gly228Glu), C4879747T (Ser258Leu) and G4879729C (Thr264Ser). Linkage disequilibrium analysis revealed four haplotype blocks in the FTO region: block 1 (M1 and M3), 2 (M8 and M9), 3 (M10-M14) and 4 (M16-M18) (Supplementary Figure 2) . Associations of chicken FTO SNP with growth, body composition and fatness traits Significant associations were found for each of 18 SNPs in FTO with various biological traits in chickens. Notably, M1, M3, M16 and M17 were significantly or highly significantly associated with many growth, body composition and fatness traits (Table 1) , and each of the remaining SNPs was also associated with a couple of the same traits (Supplementary Table 4 ).
DISCUSSION
Identification of FTO and its alternative splicing in birds Determining the existence of FTO in birds and its conservation among a wide range of species indicates that FTO is a crucial gene for animal species in addition to mammals. We identified FTO1 and FTO2 in chicken, goose and duck, and found that the complete transcript of FTO1 was conserved among vertebrates, from fish to humans. Surprisingly, through a BLAST search in GeneBank, we also found this gene present in invertebrates (S. kowalevskii) and four algae (Micromonas Ost. loc). This is a new discovery, in which it was previously assumed that FTO was not present in the pre-vertebrate genome. Additional sequence analysis revealed that all 22 species, from invertebrates to vertebrates, shared four conservative functional regions of FTO. Recently, the crystal structure of human FTO revealed that it is an AlkB-like DNA/RNA demethylase comprising an amino-terminal AlkB-like domain (residues 32 --326) and a carboxy-terminal domain (residues 327 --498) with a novel fold, and two domains interacting with each other. 36 The conserved FTO functional regions are likely related to essential functions.
Many FTO transcripts were previously identified in mammals such as human, mouse and pig. 37, 38 We cloned different transcripts of FTO in the chicken (cFTO1-cFTO4), duck (dFTO1, dFTO2 and dFTO4) and goose (gFTO1, gFTO2, and gFTO5). Alignment of FTO indicated that the encoded precursors of FTO4 and FTO5 retained the AlkB-like domain, but the domain was lost in FTO2 and FTO3. This finding suggests that FTO4 and FTO5 probably retained a partially functional DNA/RNA demethylase, which is an important aspect of FTO's bioactivity. Among the three avian species, FTO used different splicing mechanisms to form various transcripts. Among all truncated transcripts, only the isoform with 583 bp deletion (FTO2) was present in all the species. Exon 3, which encodes the AlkB-like function domain, appears to be a hot spot for alternative splicing of FTO in birds. Moreover, as the peptides encoded by cFTO2 (73 AA), cFTO3 (228 AA) and cFTO4 (283 AA) were much shorter than the full-length FTO protein (507AA), cFTO1 is predicted to be the only transcript with complete bioactivity.
Expression and effects of FTO on glucose and fat metabolism in chicken FTO expression was different for various transcripts and among chickens with divergent growth and fat characteristics. In the current study, significant differences of cFTO1 expression were found between QYP and WRR, two chicken breeds that are divergent in growth rate and fat content, indicating that FTO may be related to growth and fat metabolism in the chicken. In the cerebellum, we found the cFTO1 mRNA level of WRR was significantly higher than that of QYP, which indicates that FTO might display some function in the cerebellum. Actually, similar results were found in mammals. The levels of FTO transcript in the cerebellum of high-cholesterol fed pigs were significantly higher than the controls. 39 Also, in human and rat, FTO had the nearly high expression in the cerebellum and hypothalamus. 37 The large impact of fasting and high-glucose/fat diets on cFTO1 and PGC1a expression strongly suggest a role of FTO in glucose and energy metabolism in the chicken. Fasting decreased cFTO1 expression in the pituitary, anterior hypothalamus, posterior hypothalamus and abdominal fat, but it increased FTO1 expression in the rest tissues. A previous study reported that fasting decreased FTO expression in murine hypothalamus. 29 The high-fat diet increased cFTO1 expression in the chicken's anterior hypothalamus and posterior hypothalamus, which is consistent with the effect reported in rats. 30 Expression of FTO1 was markedly increased by the high-glucose diet, indicating that FTO might affect glucose metabolism in birds. However, prior reports conflict about the role of FTO on glucose metabolism. 24, 29, 30 Some of these discrepancies may arise from the use of different populations, tissues, methods and transcripts. In this study, highglucose diet showed more dominant effect than high-fat diet on both FTO and PGC1a expression, which provides helpful information to further investigate the link between various diet and obesity phenotype.
The upregulation of PGC1a expression by FTO indicates that FTO might regulate energy balance through PGC1a. Fasting, highglucose and high-fat diets all altered PGC1a and FTO expression in a positively correlated manner. This positive correlation was also found in mammals. 33 In this study, FTO overexpression significantly increased PGC1a, STAT3 and HL expression in CEF cells. PGC1a is a key transcriptional coactivator that directly affects energy metabolism and regulates the expression of a group of metabolism-related genes. 40 --45 Recently, non-CpG methylation of the PGC1a promoter was reported to reduce gene expression in human. 46 The positive correlation of FTO and PGC1a expression seems to prove that FTO encodes a 2-oxoglutarate-dependent nucleic acid demethylase. 29 As STAT3 and HL are two key genes for glucose and fat metabolism, 47, 48 their interaction with FTO overexpression suggests that FTO probably regulates food intake, glucose and fat metabolism through the STAT3 and HL pathways. FTO also increased the expression of GHSR, AMPKb, IGF1R, Leptin-R and PPARa, but these effects are less obvious and are not significant (P40.05).
Genetic variation and effects of FTO on production traits The association analysis conducted in the present study demonstrated large genetic effects of FTO variation on chicken phenotypes. A total of 65 SNPs were identified in 8005 bp of chicken FTO, including five non-synonymous ones. The flanking and UTR region had the highest SNP density compared with exons and introns. Linkage disequilibrium analysis revealed four haplotype blocks in the FTO region. In humans, 23 SNPs gave rise to five haplotype blocks in the whole FTO region. 3 The similarity in haplotype block number between human and chicken supports the conservation of important structural and functional features of this gene.
Several SNPs in chicken FTO were significantly associated with growth, body composition and fatness traits. Among these SNPs, M1 (with growth and body composition traits), M3 (with growth traits), M16 (with body composition traits) and M17 (with growth and fatness traits) had higher effects than the other SNPs. Several SNPs in intron 1 of chicken FTO (especially rs9939609) showed credible associations with obesity, similar to findings in various human populations. 7, 17, 18 In the pig, FTO SNPs are also related to intramuscular fat content and growth rate traits. 27, 28 The associations of FTO SNPs with body weight, body composition and fatness traits in chickens supports the functional importance of FTO in birds, similar to that in mammals. Whether the mode of action of these SNPs is by altered FTO bioactivity (M16, or Ala467Val) or by influencing FTO expression (M1-M15, M17) still awaits confirmation. These SNPs may be either in close linkage with an effective QTL or a causative mutation with crucial bioactivity.
In summary, this study provides the first detailed characterization of the FTO gene in multiple avian species. Variant avian FTO transcripts were identified. In the chicken, fasting, high-glucose and high-fat diets significantly affected cFTO1 and PGC1a expression. Overexpression of FTO in cultured cells significantly upregulated PGC1a, STAT3 and HL gene expression. Multiple SNPs in FTO were significantly associated with body weight, body composition and fatness traits in chickens. Our data indicate that FTO is involved in body weight, glucose and fat metabolism in birds.
